ABPI VPAS Report
- editorial
All work done at tothepoint and had input by the team
The Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), signed in 2019, aimed to balance NHS medicine expenditure with improving patient access, supporting innovation, and ensuring financial predictability. ABPI believes now is the time for a more ambitious settlement to drive the UK’s health and wealth.
A key goal of our brand refresh was to reinforce ABPI’s authority and credibility within the pharmaceutical industry. The updated branding delivers greater impact—essential when communicating with academics, government bodies, and NHS trusts.
